tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market

Royalty Pharma (RPRX) Ratios

Compare
1,257 Followers

Royalty Pharma Ratios

RPRX's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, RPRX's free cash flow was decreased by $ and operating cash flow was $0.88. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.19 7.90 2.19 16.81 8.76
Quick Ratio
2.19 7.90 2.19 16.81 6.63
Cash Ratio
1.47 2.96 1.47 9.00 3.28
Solvency Ratio
<0.01 0.24 <0.01 0.07 0.08
Operating Cash Flow Ratio
1.84 18.51 1.84 11.78 6.61
Short-Term Operating Cash Flow Coverage
2.15 0.00 2.15 0.00 0.00
Net Current Asset Value
$ -4.73B$ -5.02B$ -4.73B$ -4.39B$ -3.43B
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.37 0.42 0.41 0.28
Debt-to-Equity Ratio
1.26 0.94 1.26 1.23 0.59
Debt-to-Capital Ratio
0.56 0.48 0.56 0.55 0.37
Long-Term Debt-to-Capital Ratio
0.52 0.48 0.52 0.55 0.37
Financial Leverage Ratio
2.99 2.51 2.99 3.03 2.13
Debt Service Coverage Ratio
0.63 10.08 0.63 4.16 3.42
Interest Coverage Ratio
5.20 7.97 5.20 8.61 10.16
Debt to Market Cap
0.41 0.49 0.41 0.43 0.31
Interest Debt Per Share
16.68 14.13 16.68 17.51 15.91
Net Debt to EBITDA
5.82 3.00 5.82 3.82 2.86
Profitability Margins
Gross Profit Margin
99.75%76.19%99.75%99.00%95.85%
EBIT Margin
18.69%80.15%18.69%62.49%87.61%
EBITDA Margin
41.51%80.15%41.51%63.50%79.34%
Operating Profit Margin
43.69%63.37%43.69%62.49%75.16%
Pretax Profit Margin
10.28%72.20%10.28%54.21%80.21%
Net Profit Margin
1.91%48.20%1.91%20.91%23.34%
Continuous Operations Profit Margin
10.28%72.20%10.28%54.21%80.21%
Net Income Per EBT
18.62%66.75%18.62%38.57%29.10%
EBT Per EBIT
23.54%113.94%23.54%86.75%106.71%
Return on Assets (ROA)
0.25%6.93%0.25%2.73%2.35%
Return on Equity (ROE)
0.76%17.39%0.76%8.29%5.00%
Return on Capital Employed (ROCE)
6.25%9.20%6.25%8.25%7.67%
Return on Invested Capital (ROIC)
1.09%9.20%1.09%3.18%3.31%
Return on Tangible Assets
0.25%6.93%0.25%2.73%2.35%
Earnings Yield
0.25%9.03%0.25%2.90%2.64%
Efficiency Ratios
Receivables Turnover
3.07 3.04 3.07 3.35 3.39
Payables Turnover
0.72 36.97 0.72 4.09 8.18
Inventory Turnover
5.67M 0.00 5.67M 23.00M 0.13
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.13 0.14 0.13 0.13 0.10
Working Capital Turnover Ratio
1.09 1.88 1.09 0.90 1.47
Cash Conversion Cycle
-390.18 110.28 -390.18 19.63 2.79K
Days of Sales Outstanding
118.76 120.15 118.76 108.83 107.74
Days of Inventory Outstanding
<0.01 0.00 <0.01 <0.01 2.72K
Days of Payables Outstanding
508.94 9.87 508.94 89.20 44.64
Operating Cycle
118.76 120.15 118.76 108.83 2.83K
Cash Flow Ratios
Operating Cash Flow Per Share
4.90 6.68 4.90 4.86 5.42
Free Cash Flow Per Share
9.56 6.68 9.56 4.87 11.27
CapEx Per Share
4.66 0.00 4.66 <0.01 5.85
Free Cash Flow to Operating Cash Flow
1.95 1.00 1.95 1.00 2.08
Dividend Paid and CapEx Coverage Ratio
0.90 8.34 0.90 7.06 0.78
Capital Expenditure Coverage Ratio
1.05 0.00 1.05 3.86K 0.93
Operating Cash Flow Coverage Ratio
0.30 0.49 0.30 0.28 0.35
Operating Cash Flow to Sales Ratio
0.96 1.27 0.96 0.88 0.96
Free Cash Flow Yield
24.18%23.76%24.18%12.21%22.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
404.10 11.08 404.10 34.53 37.95
Price-to-Sales (P/S) Ratio
7.74 5.34 7.74 7.22 8.86
Price-to-Book (P/B) Ratio
3.08 1.93 3.08 2.86 1.90
Price-to-Free Cash Flow (P/FCF) Ratio
4.14 4.21 4.14 8.19 4.44
Price-to-Operating Cash Flow Ratio
8.07 4.21 8.07 8.19 9.24
Price-to-Earnings Growth (PEG) Ratio
-4.42 <0.01 -4.42 -2.68 -0.48
Price-to-Fair Value
3.08 1.93 3.08 2.86 1.90
Enterprise Value Multiple
24.46 9.66 24.46 15.19 14.02
Enterprise Value
22.71B 18.23B 22.71B 22.08B 23.60B
EV to EBITDA
24.46 9.66 24.46 15.19 14.02
EV to Sales
10.15 7.74 10.15 9.65 11.12
EV to Free Cash Flow
5.43 6.10 5.43 10.94 5.58
EV to Operating Cash Flow
10.59 6.10 10.59 10.95 11.60
Tangible Book Value Per Share
21.72 22.53 21.72 24.69 39.80
Shareholders’ Equity Per Share
12.85 14.58 12.85 13.93 26.36
Tax and Other Ratios
Effective Tax Rate
0.81 0.00 0.81 0.61 0.67
Revenue Per Share
5.11 5.26 5.11 5.52 5.65
Net Income Per Share
0.10 2.54 0.10 1.15 1.32
Tax Burden
0.19 0.67 0.19 0.39 0.29
Interest Burden
0.55 0.90 0.55 0.87 0.92
Research & Development to Revenue
0.08 0.02 0.08 0.09 0.01
SG&A to Revenue
0.10 0.11 0.10 0.08 0.09
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
9.32 1.76 9.32 1.63 1.20
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis